Johnny D. Hoskins, DVM, PhD, DACVIM

Dr. Johnny Hoskins is owner of DocuTech Services. He is a diplomate of the American College of Veterinary Internal Medicine and he is a member of DVM Newsmagazine's Editorial Advisory Board.

Articles by Johnny D. Hoskins, DVM, PhD, DACVIM

Canine hemangiosarcoma (HSA) is an incurable tumor of vascular endothelial cells. HSA accounts for 7 percent of all cancers; thus, of the 65 million pet dogs living in the United States today, between 1.5 million and 2.5 million could get HSA and succumb to it. Although dogs of any age and breed are susceptible to HSA, it occurs more commonly in dogs beyond middle age and in breeds such as Golden Retrievers, German Shepherds, Portuguese Water Dogs and Skye Terriers. The estimated life-time risk of HSA in Golden Retrievers is one in five, illustrating the magnitude of this problem.